-
Technological innovation is making pharmaceutical equipment companies glow with "new vitality"
Time of Update: 2022-04-15
Technological innovation is bringing "new vitality" to pharmaceutical equipment companies (Source: Pharmaceutical Network) For example, on January 10, Tofflon's 2021 performance pre-increase announcement showed that the expected net profit is 765 million yuan to 9.
-
Opportunities and challenges coexist in the traditional Chinese medicine formula granule industry, how should enterprises respond?
Time of Update: 2022-04-15
In the context of the ever-changing environment in the pharmaceutical industry, the company continues to carry out innovation, transformation and upgrading, strengthen brand and channel construction, increase innovation investment, improve operational quality and efficiency, and stabilize its position in the industry.
-
The Centralized Procurement Alliance of Chinese Patent Medicines in 6 Provinces is approaching, and a large number of medicines will be reduced in price
Time of Update: 2022-04-15
[Pharmaceutical Network Market Analysis] In recent years, many places have carried out centralized procurement pilots for some varieties of Chinese patent medicines with high demand and high price .
-
In 2024, the traditional Chinese medicine market may exceed 1 trillion yuan!
Time of Update: 2022-04-15
At the same time, the investment of traditional Chinese medicine companies in the research and development of new drugs has also continued to increase .
-
Strengthening the supervision of medical devices in many places, equipment companies are facing big challenges
Time of Update: 2022-04-15
For example, in order to strengthen the supervision of online sales enterprises of medical devices and improve the level of quality and safety management, the Market Supervision Bureau of Wuqing District, Tianjin recently launched the 2022 governance action of "online and offline regulations" for medical devices, both online and offline.
-
Under the escort of the policy, the Chinese medicine industry is expected to usher in a new life!
Time of Update: 2022-04-15
Among them, in terms of the traditional Chinese medicine formula granule business, the company continued to strengthen the national production capacity layout, continued to improve the market coverage and the penetration rate of the stock market, and achieved a significant increase in revenue and profit compared with the same period of the previous year .
-
This pharmaceutical stock hit the daily limit again, gaining 6 boards in 8 days!
Time of Update: 2022-04-15
Affected by this news, from March 2nd to 4th, Sinopharm had the daily limit for three consecutive trading days .
It is worth mentioning that on March 11, affected by the news of the cooperation between China Pharmaceuticals and Pfizer, Changjiang Health and Peking University Pharmaceuticals also increased their daily limit.
-
Pension concept stocks continue to be popular, and many stocks such as Yuexin Health have daily limit
Time of Update: 2022-04-15
Several pharmaceutical stocks involving the concept of elderly care have risen sharply today, including Yuexin Health, Dongcheng Pharmaceutical, Dean Diagnostics, Xiangyu Medical, Taiji Group, etc.
The two parties plan to jointly initiate the establishment of Nuokai Dongcheng Nuclear Pharmaceutical Industry Investment fund (limited partnership) with a fund size of 500 million yuan .
-
The pharmaceutical rivers and lakes are surging, and a group of local pharmaceutical company executives have returned to multinational pharmaceutical companies!
Time of Update: 2022-04-15
According to the data, Qian Wei has more than 25 years of rich experience in the pharmaceutical industry, and has worked in large multinational pharmaceutical companies such as Eli Lilly, AstraZeneca, and Roche .
-
1 new pharmaceutical stock is subscribed today, focusing on the field of domestic small molecule innovative drugs
Time of Update: 2022-04-15
This product is the second-generation ALK kinase inhibitor independently developed by the company, which is used for the treatment of advanced ALK-positive non-small cell lung cancer.
-
The Chinese medicine market has opened up, and institutions have been investigating!
Time of Update: 2022-04-15
For example, Zhenbao Island stated in its investor relations activity record sheet released on March 29 that the company accepted four institutional surveys on March 25, 2022, with the types of institutions being insurance companies, fund companies, and securities companies .
-
The inflection point of the traditional Chinese medicine industry has come, and the Nuggets have 3 sub-tracks
Time of Update: 2022-04-15
[Pharmaceutical Network Market Analysis] In recent years, with the establishment and improvement of industry standards, mechanisms and service systems, the traditional Chinese medicine industry has gradually presented a good situation of equal emphasis on traditional Chinese and Western medicine, support and regulation, inheritance and innovation.
-
How to open the ceiling of the pharmaceutical equipment industry?
Time of Update: 2022-04-15
In recent years, innovative drugs including antibody drugs, cell therapy, and gene drugs have flourished, bringing new development opportunities to the upstream equipment and consumables industries .
-
12 pharmaceutical stocks daily limit, belonging to traditional Chinese medicine, pharmaceutical business and other sectors
Time of Update: 2022-04-15
According to the data, Gongtong Pharmaceutical is a company specializing in the research and development, production and sales of steroid drug raw materials.
-
Industry: The domestic pharmaceutical equipment industry has ushered in the third opportunity for rapid development
Time of Update: 2022-04-15
Pharmaceutical equipment (photo source: Pharmaceutical Network) In terms of the current domestic biopharmaceutical equipment market scale, data shows that in 2020, China's biopharmaceutical equipment and consumables represented by reactor systems, disposable reaction bags, chromatography equipment, etc.
-
The development of the traditional Chinese medicine formula granule industry has entered a new stage, and the transformation and upgrading of pharmaceutical enterprises is urgent
Time of Update: 2022-04-15
In recent years, with the enhancement of residents' awareness of health care, the continuous release of policy dividends, and the active deployment of a large number of enterprises, the market of traditional Chinese medicine granules has maintained a rapid growth trend .
-
In 2022, these traditional Chinese medicine subdivisions may break out!
Time of Update: 2022-04-15
The industry believes that the future expansion of the traditional Chinese medicine formula market is expected to accelerate, and the filing system and the new national standard will build high industry barriers .
-
The pharmaceutical equipment industry is developing rapidly, and the market prospect of tangential flow filtration is optimistic
Time of Update: 2022-04-15
The pharmaceutical equipment industry is developing rapidly, and the market prospect of tangential flow filtration is promising.
Overall, there are relatively few domestic manufacturers with independent research and development capabilities in the domestic tangential flow filtration market, and their brand strength is not as strong as that of foreign-funded enterprises.
-
Since 2022, many pharmaceutical companies have ceased production and no longer operate, and the pharmaceutical market reshuffle has intensified!
Time of Update: 2022-04-15
On January 21, the Gansu Provincial Food and Drug Administration issued an announcement to cancel the "Drug Production License" of 10 pharmaceutical companies .
In addition, in January, the Yunnan Provincial Food and Drug Administration also issued a number of announcements to cancel the "Drug Production License" of the enterprise .
-
The pharmaceutical industry is pushing for intelligent transformation to improve production efficiency and product quality
Time of Update: 2022-04-15
From the above point of view, through the implementation of intelligent transformation, pharmaceutical companies can achieve cost reduction and efficiency improvement, which has become an important starting point for promoting the high-quality development of the pharmaceutical industry .
